“Patient journeys” is an initiative designed to help patients and clinicians improve care for rare lung diseases, including pulmonary hypertension (PH). The project, announced in a press release from the European Reference Network on Rare Respiratory Diseases (ERN-LUNG), presents testimonies showing the clinical history and needs of patients through…
A total of approximately 5.8 new cases per one million inhabitants was found to be the most accurate value for the worldwide incidence of pulmonary arterial hypertension (PAH), according to a review study. That incidence value — the rate of occurrence of new cases of a disease — ranged…
United Therapeutics is now among the leading sponsors of the Pulmonary Fibrosis Foundation (PFF) Registry, a research data resource for pulmonary fibrosis (PF) that is expanding to include pulmonary hypertension (PH) associated with PF, the foundation announced. Pulmonary hypertension that develops during the course of PF (characterized by scarring…
A bike competition to educational meetings and daily walks, runs, or meditations are among the events Team PHenomenal Hope is hosting throughout November to honor pulmonary hypertension (PH) awareness month. People are invited to join the nonprofit group’s Tour of PHenomenal Hope and its monthlong series, ranging from educational sessions, physical…
The Pulmonary Hypertension Association (PHA) is promoting several events throughout November — the Pulmonary Hypertension (PH) Awareness Month. This year, people are encouraged to discover the risk factors and symptoms of PH, and the challenges faced by those living with the disease, and their families. PH…
Letairis (ambrisentan), an approved therapy for pulmonary arterial hypertension (PAH) in adults, appears to also be effective and safe in children ages 8 and older, a study based on clinical trial data reports. All doses tested were well tolerated by children with PAH, and Letairis’ benefit-risk profile was similar to…
Pulmonary hypertension (PH) may be induced by an increased dosage of diazoxide, a therapy used to treat low blood sugar, a case report suggests. The study highlights the need for regular echocardiograms (ECG) during diazoxide treatment to detect PH early. The report, “Pulmonary Hypertension Following Increased…
Get regular updates to your inbox.